The 13th meeting of the Russian-Arab Business Council session was held on 25-26 January.
Russia’s pharmaceutical industry has managed not only to adapt to the new challenges brought forth amid the ongoing coronavirus pandemic, but continues to remain open to cooperation with the country’s partners in the Arab world, said Prof. Dmitry Kudlay, vice president of new medical technologies implementation at Russian pharmaceutical company Generium.
Kudlay delivered this remark at a roundable discussion on matters of healthcare and pharmaceutical industry development that was held during a meeting of the Russian-Arab Business Council this week at Expo 2020 in Dubai.
Kudlay remarked:
According to a forecast for Russia’s scientific and technological development till year 2030, cellular, genome and post-genome technologies will serve as foundation for preventing the spread of various types of diseases, including transmissible infections of humans and animals.
Kudlay stated:
For the global biotechnological development in the mid- and long-term perspective, it is important not to miss the window of opportunity that has been afforded to us by global cooperation related to challenges posed by the COVID-19 pandemic.
